129 related articles for article (PubMed ID: 9743260)
1. First-pass metabolism of 5-fluorouracil in the perfused rat small intestine.
Gu J; Yuasa H; Hayashi Y; Watanabe J
Biol Pharm Bull; 1998 Aug; 21(8):871-3. PubMed ID: 9743260
[TBL] [Abstract][Full Text] [Related]
2. Absorption and metabolic extraction of diltiazem from the perfused rat small intestine.
Iwao T; Inoue K; Hayashi Y; Yuasa H; Watanabe J
Drug Metab Pharmacokinet; 2004 Dec; 19(6):430-7. PubMed ID: 15681897
[TBL] [Abstract][Full Text] [Related]
3. First-pass metabolism of 5-fluorouracil in rats.
Yuasa H; Gu J; Hayashi Y; Watanabe J
J Pharm Pharmacol; 1998 Sep; 50(9):1019-25. PubMed ID: 9811163
[TBL] [Abstract][Full Text] [Related]
4. Effect of coadministered uridine on intestinal first-pass metabolism of 5'-deoxy-5-fluorouridine in conscious rats--an evaluation by method of portal-systemic concentration difference.
Sawai Y; Yamaoka K; Nakagawa T
Pharm Res; 1998 Jul; 15(7):1007-11. PubMed ID: 9688052
[TBL] [Abstract][Full Text] [Related]
5. Moment analysis of intestinal first-pass metabolism by portal-systemic concentration difference in single conscious rat using 5'-deoxy-5-fluorouridine and 5-fluorouracil as model drug system.
Sawai Y; Yamaoka K; Takemura A; Nakagawa T
J Pharm Sci; 1997 Nov; 86(11):1269-72. PubMed ID: 9383738
[TBL] [Abstract][Full Text] [Related]
6. Metabolic extraction of nifedipine during absorption from the rat small intestine.
Iwao T; Inoue K; Hayashi Y; Yuasa H; Watanabe J
Drug Metab Pharmacokinet; 2002; 17(6):546-53. PubMed ID: 15618710
[TBL] [Abstract][Full Text] [Related]
7. Simultaneous evaluation of intestinal absorption and hepatic extraction of 5-fluorouracil using portal-systemic concentration difference by short-period double dosing in a single conscious rat.
Sawai Y; Yamaoka K; Ito T; Nakagawa T
Biol Pharm Bull; 1997 Dec; 20(12):1313-6. PubMed ID: 9448112
[TBL] [Abstract][Full Text] [Related]
8. Enhanced glucose absorption in the rat small intestine following repeated doses of 5-fluorouracil.
Tomimatsu T; Horie T
Chem Biol Interact; 2005 Aug; 155(3):129-39. PubMed ID: 15996645
[TBL] [Abstract][Full Text] [Related]
9. Intestinal brush border transport mechanism of 5-fluorouracil in rats.
Yuasa H; Matsuhisa E; Watanabe J
Biol Pharm Bull; 1996 Jan; 19(1):94-9. PubMed ID: 8820919
[TBL] [Abstract][Full Text] [Related]
10. Dose-dependent gastrointestinal absorption of 5-fluorouracil in rats in vivo.
Yuasa H; Matsuda K; Gu J; Suzuki E; Yokouchi I; Watanabe J
Biol Pharm Bull; 1996 Nov; 19(11):1494-8. PubMed ID: 8951171
[TBL] [Abstract][Full Text] [Related]
11. Effect of aging on the intestinal transport of hydrophilic drugs in the rat small intestine.
Yuasa H; Soga N; Kimura Y; Watanabe J
Biol Pharm Bull; 1997 Nov; 20(11):1188-92. PubMed ID: 9401730
[TBL] [Abstract][Full Text] [Related]
12. An assessment of mucosal damage in vivo: effect of oral pretreatment with 5-fluorouracil on the intestinal first-pass metabolism of salicylamide in rabbits.
Nakamura J; Katayama M; Nishida K; Sasaki H
Chem Pharm Bull (Tokyo); 1992 Apr; 40(4):1011-5. PubMed ID: 1525929
[TBL] [Abstract][Full Text] [Related]
13. Absorption of 5-fluorouracil and related pyrimidines in rat small intestine.
Bronk JR; Lister N; Lynch S
Clin Sci (Lond); 1987 Jun; 72(6):705-16. PubMed ID: 3595076
[TBL] [Abstract][Full Text] [Related]
14. Role of intestinal first-pass metabolism of baicalein in its absorption process.
Zhang L; Lin G; Chang Q; Zuo Z
Pharm Res; 2005 Jul; 22(7):1050-8. PubMed ID: 16028005
[TBL] [Abstract][Full Text] [Related]
15. The bioavailability of polyphenols is highly governed by the capacity of the intestine and of the liver to secrete conjugated metabolites.
Silberberg M; Morand C; Mathevon T; Besson C; Manach C; Scalbert A; Remesy C
Eur J Nutr; 2006 Mar; 45(2):88-96. PubMed ID: 15981077
[TBL] [Abstract][Full Text] [Related]
16. The anti-cancer drug 5-fluorouracil is metabolized by the isolated perfused rat liver and in rats into highly toxic fluoroacetate.
Arellano M; Malet-Martino M; Martino R; Gires P
Br J Cancer; 1998; 77(1):79-86. PubMed ID: 9459149
[TBL] [Abstract][Full Text] [Related]
17. Carrier-mediated transport of glycerol in the perfused rat small intestine.
Ohta KY; Inoue K; Hayashi Y; Yuasa H
Biol Pharm Bull; 2006 Apr; 29(4):785-9. PubMed ID: 16595918
[TBL] [Abstract][Full Text] [Related]
18. Phosphatidylcholine does not protect rats against 5-fluorouracil/folinic acid-induced damage of the intestinal luminal mucosa.
Fittkau M; Gerlach R; Schmoll HJ
J Cancer Res Clin Oncol; 2002 Feb; 128(2):80-4. PubMed ID: 11862477
[TBL] [Abstract][Full Text] [Related]
19. First-pass metabolism of ONO-5046 (N-[2-[4-(2,2-dimethylpropionyloxy) phenylsulfonylamino]benzoyl]aminoacetic acid), a novel elastase inhibitor, in rats.
Watanabe F; Sato M; Kato A; Murakami T; Higashi Y; Yata N
Biol Pharm Bull; 1997 Apr; 20(4):392-6. PubMed ID: 9145216
[TBL] [Abstract][Full Text] [Related]
20. Effects of 5-fluorouracil on the drug-metabolizing enzymes of the small intestine and the consequent drug interaction with nifedipine in rats.
Yoshisue K; Nagayama S; Shindo T; Kawaguchi Y
J Pharmacol Exp Ther; 2001 Jun; 297(3):1166-75. PubMed ID: 11356943
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
